#marijuana testing

 In 2023, the worldwide market for testing cannabis was worth $1.72 billion. It's estimated to increase at an average annual rate of 22.8% from 2023 to 2035. The report thoroughly examines the current market situation, its size, and the probable future growth of the marijuana testing market size throughout this forecast period. Obtain a comprehensive study for more details!

Cannabis & Marijuana Testing Market Size | Share, Trends | Analysis(2035)   

Connecticut is joined by only Florida and Maryland in setting the mold limit as high as 100,000 CFU/g. But safety standards vary widely across the nation. Branford resident Alex London uses cannabis to help with lingering back pain and migraines that stem from a car crash. London said he used to buy it from medical marijuana dispensaries near his home. But now, because of changes in how…

Legal cannabis poses a quandary for US companies screening staff for drugs

Workers at Wyatt Bassett’s furniture factory in Virginia use powerful tools to churn out the company’s trademark dressers and headboards, so screening new hires for drugs is a no-brainer. Or it used to be. Virginia last year fully legalized marijuana — the first state in the South to do so. The upshot is that “being positive for cannabis does not necessarily disqualify you for employment,” said…

South Dakota adds new standards for testing medical cannabis

The South Dakota Legislative Rules Committee passed new rules Tuesday that adds regulations for testing medical cannabis. The rules would also clarify tracking system requirements, and with the latest legislative changes, according to the Department of Health. Several bills related to medical cannabis were signed into law in March. Senate Bill 19 permits some facilities to establish restrictions…

NYPD walks back decision to end of marijuana testing for officers

The New York Police Department announced Wednesday it would no longer randomly test police officers or job applicants for marijuana, but then subsequently sought to walk back that directive. An internal memo shared with the Times Union, which was authored by the department’s deputy commissioner for legal affairs, said the policy will align with state Labor Law that prohibits adverse employment…

Utah isn’t testing medical marijuana for potential disease-causing contaminants. Robert Gehrke explains why.

Due to an equipment shortage, the state said it suspended testing for E.coli, salmonella and several kinds of molds that cause illness, especially among the immunocompromised. For over a year, Utah has not been testing medical marijuana for several pathogens in the plants that could be harmful to patients, particularly those with compromised immune systems. Last April, the Utah Department of…